Pegylated Interferon - α2b With SARSCoV- 2 (COVID-19)

NCT04480138 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

7

Enrollment

INDUSTRY

Sponsor class

Stopped Due to non availability of eligible subjects and slow recruitment

Conditions

Covid19

Interventions

DRUG: Pegylated Interferon-α2b
OTHER: Standard of Care

Sponsor

Zydus Lifesciences Limited